| Full Name | Erin Wardrop |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 50 Chestnut St, Dover, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003589284 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erin Wardrop, 113 Crosby Rd Ste 1, Dover, NH 03820-4370 Ph: (603) 516-9300 | Erin Wardrop, 50 Chestnut St, Dover, NH 03820-3672 Ph: (603) 516-9300 |
News Archive
Researchers at Brandeis, in collaboration with several other institutions worldwide, have pinpointed for the first time the multi-country economic costs of dengue fever, the endemic and epidemic mosquito-borne illness that is a rapidly growing public health problem in tropical and sub-tropical countries.
Patients who've had a stroke and were rehabilitated using a robot to navigate virtual reality environments walked faster and a greater distance following physical therapy compared to those trained with the robot alone, according to researchers at the UMDNJ-School of Health Related Professions.
Most existing treatments for pathological bone loss inhibit osteoclasts (bone-destroying cells) to limit bone degradation. However, by doing this, they also prevent bone formation since it is stimulated by the presence of these very same osteoclast cells. Researchers from the CNRS, Inserm and the Université de Montpellier and Université Jean Monnet - Saint-étienne have developed a new approach for preventing the destructive activity of osteoclasts without affecting their viability.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced the company has submitted a new drug application (NDA) for ARYMO ER (morphine sulfate) extended-release tablets for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
› Verified 7 days ago
Katherine B Frick, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16 5th St, Dover, NH 03820 Phone: 603-749-4462 Fax: 603-749-2475 | |
Jennifer C Spargo, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7 Westwood Cir, Dover, NH 03820 Phone: 603-749-7827 | |
Mary Boucher, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 6 Old Rochester Rd Ste 102c, Dover, NH 03820 Phone: 603-828-2434 | |
Mrs. Kimberly Alice Whittemore, BA Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 50 Chestnut Street, Suite A, Dover, NH 03820 Phone: 603-516-9300 Fax: 603-516-2731 | |
Betsy A. Leavitt, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11 Boston Harbor Rd, Dover, NH 03820 Phone: 603-749-0558 Fax: 603-742-9523 | |
Emily Mary Nelson Walsh, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 90 Washington St Ste 301b, Dover, NH 03820 Phone: 603-836-0393 |